Phytochemicals with potential NMDAR-inhibitory activities: a review of neuroprotective mechanisms against excitotoxicity Authors: Abdulmohsin J. Alamoudi Published: 2026 ABSTRACT The N-methyl-D-aspartate receptors (NMDARs) are ionotropic glutamate receptors in the central nervous system (CNS) that play a crucial role in synaptic plasticity, learning, and memory. However, NMDAR overstimulation is a critical pathological feature in neurodegenerative diseases, stroke, epilepsy, and traumatic brain injury. This excitotoxic cascade triggers massive intracellular calcium influx, oxidative stress, and mitochondrial dysfunction, ultimately driving neuronal apoptosis. In this regard, phytochemicals have emerged as safe, multitargeting NMDAR inhibitors with significant therapeutic potential. This review synthesizes current experimental evidence regarding the neuroprotective potential of major phytochemical classes, including glycosides (e.g., vitexin, ginsenosides), polyphenols (e.g., quercetin, resveratrol), alkaloids (e.g., cytisine, huperzine A), and terpenoids (e.g., bilobalide, fucoxanthin). The results of these studies demonstrate that these bioactive compounds mitigate excitotoxicity via multiple mechanisms, including direct receptor blockade, inhibiting specific subunits (such as GluN2B), and downregulating NMDAR expression. Furthermore, they restore neuronal homeostasis by modulating downstream signaling pathways; thereby suppressing neuroinflammation and apoptosis. It can be concluded that phytochemicals represent a vital reservoir of modulatory agents that protect against glutamate-induced neurotoxicity. Hence, they offer a compelling framework for future drug discovery in CNS therapeutics. Introduction The N-methyl-D-aspartate receptors (NMDAR) are ionotropic receptors in the central nervous system (CNS) that respond to the major excitatory neurotransmitter, glutamate (Hollmann and Heinemann 1994; McBain and Mayer 1994; Zhou and Tajima 2023), and thus play a crucial role in excitatory transmission, synaptic plasticity, learning, and memory in developing as well as adult brains (Hansen et al. 2021; Tsien et al. 1996). The importance of the NMDA receptor in controlling multiple central nervous functions emerges from its ability to maintain a graded response to stimuli and control calcium access into the cell (McRoberts et al. 2001). The molecular structure of NMDARs is a heterotetrameric assembly, characteristically containing two GluN1 subunits (formerly NR1) and two subunits comprising GluN2 (A, B, C, and D) or GluN3 (A and B) variants (Cull-Candy and Leszkiewicz 2004), with the majority of the receptors composed of GluN1 and GluN2 (Ladagu et al. 2023; Vallée and Vallée, 2018), where the GluN2 subunit has an essential function in synaptic plasticity and memory (Dainauskas et al. 2023; Wang et al. 2014). Molecular characterization of the NMDAR leads to categorization of the receptors into many subtypes that are expressed in the CNS (Kutsuwada et al. 1992; Monyer et al. 1994). The two subtypes that comprise the majority of the NMDAR population in the glutaminergic neurons are the GluN2A- and GluN2B-containing NMDARs, and together represent the majority of the NMDARs in the forebrain and hippocampus of adult mammals, and can be detected on the synaptic and extrasynaptic membranes (Ladagu et al. 2023; Thomas et al. 2006). The activation of both types is associated with excitotoxicity and neuronal cell death, and cognitive impairment (Ge and Wang 2023; Jacobs and Tsien 2014; Maher et al. 2014). Altered activities of NMDA receptors have been reported in many diseases, including Alzheimer’s disease (AD) (Mota et al. 2014), Huntington’s disease (HD) (Zhang et al. 2025), major depressive disorder (Molero et al. 2018), tinnitus (Noreña, 2015), migraine (Ye et al. 2009) epilepsy, stroke, and traumatic brain injury (Zhou and Sheng 2013), where abnormal intracellular calcium levels and excitotoxicity play an important role in disease pathogenesis and NMDA antagonists showed promising therapeutic effects (Ondo et al. 2007; Zhang et al. 2025). NMDA receptors are the pharmacologic target of many drugs that are used to treat neurological disorders, including memantine, an uncompetitive NMDA antagonist used in the treatment of AD (Mota et al. 2014) and off-label for HD (Ondo et al. 2007); amantadine, a NMDA antagonist used for treating Parkinson's disease (PD) and off-label for HD (Raupp-Barcaro et al. 2018); and methadone, mu-opioid receptor agonist and NMDA antagonist that is used for treating opioid addiction (Aiyer et al. 2018). Phytochemicals have been widely used in recent times as a safer alternative to a variety of therapeutic agents. Due to the wide range of activities, multiple studies have focused on discovering their potential benefits against many diseases, including neurological diseases. Several phytochemicals from different classes, including glycosides, polyphenolics, alkaloids, and terpenoids, were found to confer neuroprotective effects through inhibiting NMDAR, as summarized in Table 1. Table 1Summary of phytochemicals with NMDA-inhibitory effects and their chemical class and major sourcesPhytochemicalChemical classMain sourceReferenceBilobalideSesquiterpene lactoneGinkgo biloba green leaves(Jensen et al. 2002)Compound MQACaffeoylquinic acid derivativeRoots of Arctium lappa L(Tian et al. 2015)CytisineAlkaloidCytisus seeds(Fitch et al. 2005)FucoxanthinXanthophyll-type carotenoidEdible brown seaweeds(Oliyaei et al. 2023)Ginsenosidessteroid glycosidesGinseng(Chopra et al. 2023)HonokiolPhenylpropanoid compound (neolignanes)Magnolia Bark(Pan et al. 2009)Huperzine AAlkaloidChinese herb Huperzia serrata (Thunb) Trev(Liu et al. 1986)Hydroxysafflor yellow AQuinochalcone C-glycoside (flavonoid glycoside)Safflower petals(Adamska and Biernacka 2021)IbogaineIndole alkaloidRoot bark of the African shrub Tabernanthe iboga(Zetler et al. 1972)MagnololPhenylpropanoid compound (neolignanes)Magnolia Bark(Pan et al. 2009)PiperineAlkaloidBlack pepper(Rauscher et al. 2000; Selvendiran et al. 2003)QuercetinFlavonoidsBroadly available in the human diet(Chang et al. 1993; Matter et al. 1992; Picq et al. 1989)ResveratrolPolyphenolic stilbeneGrapesCranberriesPeanuts(Mullin 2011)SinomenineAlkaloidSinomenium acutum(Gao et al. 2019; Liu et al. 1996)VitexinApigenin flavone glycosideBuckwheatHawthornEchinodorusBambooMung beanPassiflora(Cao et al. 2011; Gadioli et al. 2018; Kirakosyan et al. 2003; Tanus-Rangel et al. 2010; Wang et al. 2012)NMDA: N-methyl-D- aspartate Table 1Summary of phytochemicals with NMDA-inhibitory effects and their chemical class and major sourcesPhytochemicalChemical classMain sourceReferenceBilobalideSesquiterpene lactoneGinkgo biloba green leaves(Jensen et al. 2002)Compound MQACaffeoylquinic acid derivativeRoots of Arctium lappa L(Tian et al. 2015)CytisineAlkaloidCytisus seeds(Fitch et al. 2005)FucoxanthinXanthophyll-type carotenoidEdible brown seaweeds(Oliyaei et al. 2023)Ginsenosidessteroid glycosidesGinseng(Chopra et al. 2023)HonokiolPhenylpropanoid compound (neolignanes)Magnolia Bark(Pan et al. 2009)Huperzine AAlkaloidChinese herb Huperzia serrata (Thunb) Trev(Liu et al. 1986)Hydroxysafflor yellow AQuinochalcone C-glycoside (flavonoid glycoside)Safflower petals(Adamska and Biernacka 2021)IbogaineIndole alkaloidRoot bark of the African shrub Tabernanthe iboga(Zetler et al. 1972)MagnololPhenylpropanoid compound (neolignanes)Magnolia Bark(Pan et al. 2009)PiperineAlkaloidBlack pepper(Rauscher et al. 2000; Selvendiran et al. 2003)QuercetinFlavonoidsBroadly available in the human diet(Chang et al. 1993; Matter et al. 1992; Picq et al. 1989)ResveratrolPolyphenolic stilbeneGrapesCranberriesPeanuts(Mullin 2011)SinomenineAlkaloidSinomenium acutum(Gao et al. 2019; Liu et al. 1996)VitexinApigenin flavone glycosideBuckwheatHawthornEchinodorusBambooMung beanPassiflora(Cao et al. 2011; Gadioli et al. 2018; Kirakosyan et al. 2003; Tanus-Rangel et al. 2010; Wang et al. 2012)NMDA: N-methyl-D- aspartate Summary of phytochemicals with NMDA-inhibitory effects and their chemical class and major sources Grapes Cranberries Peanuts Buckwheat Hawthorn Echinodorus Bamboo Mung bean Passiflora NMDA: N-methyl-D- aspartate The current review provides a mechanistic overview of the effect of natural compounds belonging to different phytochemical classes on NMDA signaling. Existing studies generally address the neuroprotective effects of phytochemicals. One study examined their impact on glutamate transmission in general. However, the current study focuses on NMDA receptors as important targets for glutamate transmission, which contribute significantly to numerous neurological functions, including synaptic plasticity. At the same time, overstimulation poses a risk of excitotoxicity. Therefore, the current review aims to highlight the phytochemicals with potential NMDAR-blocking activity and the consequent neuroprotective effects in neurodegenerative and other neurological disorders. NMDAR activation and excitotoxicity It is well established that excitatory amino acids constitute the main excitatory neurotransmitters in the brain, especially in the cerebral cortex and hippocampus, and that their role in psychological processes, such as learning and memory, is distinct. Disruptions of the excitatory amino acid system greatly impact the pathogenesis of a wide range of neuropsychiatric syndromes, including those associated with delirium or dementia (Javitt and Zukin 1990; Pal 2021; Wang et al. 2024a, b, c). However, the overactivity of excitatory amino acids and uncontrolled binding to their receptors are associated with excitotoxicity, which is defined as cell death due to the toxic effects of excitatory neurotransmitters that mediate excessive depolarization of the postsynaptic membrane. Glutamate is the major excitatory neurotransmitter in the CNS that activates the NMDAR, hence neuronal excitotoxicity generally indicates neuronal injury and death after continued exposure to glutamate, and consequently, the excessive entry of ions into neurons, which is represented in calcium overburden (Nicosia et al. 2024). Abnormal intracellular loads of calcium are predominantly neurotoxic, enhancing mechanisms leading to neuronal death due to the resultant activation of the catabolic enzymes, comprising proteolytic enzymes, lipases, and nucleases (Nicosia et al. 2024). Mitochondria work as the energy powerhouses and buffering sinks of the cell. Besides their role in oxidative phosphorylation and cellular respiration, they play a critical role in maintaining a low cytoplasmic calcium concentration. Alterations in any of these functions have remarkable consequences and often determine the cell’s fate in survival/death signaling pathways. Particularly, excessive calcium uptake, due to the overactivation of glutamate receptors, or the generation of ROS, prompts the activation of the mitochondrial permeability transition and the consequent release of calcium and proapoptotic factors into the cytoplasm (Bock and Tait 2020). Studies revealed that oxidative stress, besides its damaging effect on the cellular macromolecules through the overproduction of reactive oxygen species (ROS), contributes to excitotoxicity, predominantly via the overproduction of nitric oxide (NO) and its highly reactive oxidant form peroxonitrite (ONOO−), which regulates excitotoxicity and induces oxidative DNA damage (Brown and Bal-Price 2003; Nicosia et al. 2024). Moreover, activated NMDA receptors in turn activate NADPH oxidase and consequently induce the production of superoxide molecules that, besides being damaging to the nerve cells, they produces hydroxyl radicals and can interact with NO, producing ONOO− where both have potent neurotoxic effects (Bal-Price et al. 2002; Brennan et al. 2009; Cobb and Cole 2015). Therefore, phytochemicals with antioxidant characteristics can consequently reduce excitotoxicity (Adhikary et al. 2025). Phytochemicals with potential NMDAR inhibitory activity Current treatments for neurological disorders are effective in ameliorating symptoms; however, only a few can delay disease progression and are associated with a wide range of adverse effects. On the other hand, phytochemicals are characterized by a wide therapeutic index and may be of pronounced impact in managing diseases (Ghosh et al. 2025). Multiple studies have been conducted on different experimental models that showed potential therapeutic advantages of phytochemicals through inhibiting NMDAR activity and/or expression (Table 2). Table 2The main experimental models employed in testing the NMDA-inhibiting activities of some phytochemicalsPhytochemical ClassPhytochemical compoundModelImpact of inhibiting NMDAReferenceGlycosidesVitexinCultured cortical neuronsReducing neuronal apoptosis(Yang et al. 2014)Ginsenoside Rb1Secondary brain damage due to strokes in ratsReducing neuronal apoptosis and increasing the regional cerebral blood flow(Wang et al. 2017)Ginsenoside Rg1Repeated alcohol exposure-induced psychomotor and cognitive deficits in miceImproved the cognitive behavior, and suppressed the extrasynaptic NMDARs-mediated excitotoxic signaling(Huang et al. 2020a)Hydroxysafflor yellow ANMDAR-mediated neurotoxicity in rat primary neuronsPrevented excitotoxic neuronal death(Yang et al. 2010)Neuronal injury induced by oxygen and glucose deprivation in mice hippocampal slicesPrevented excitotoxic neuronal death(Wang et al. 2016)PolyphenolicsQuercetinBulbectomized miceAlleviated the signs of depression(Holzmann et al. 2015)ResveratrolNMDA-induced seizure in different modelsIncreased the NMDA-induced seizure thresholds and reduced neuronal death(Wang et al. 2019)HonokiolNMDA-induced seizures in miceIncreased the NMDA-induced seizure thresholds(Lin et al. 2005)MagnololNMDA-induced seizures in miceIncreased the NMDA-induced seizure thresholds(Lin et al. 2005)Compound MQANMDA-treated SH-SY5Y cellsInhibit NMDA-induced calcium influx(Tian et al. 2015)AlkaloidsCytisineCultured cortical neural injury induced by NMDAPrevented the decline in cell viability and prevented neuronal apoptosis(Li et al. 2013)Cerebral ischemic–reperfusion injury in miceReduced the brain infarction size and inhibited neuronal apoptosis(Zhao et al. 2018)Huperzine ANMDA-induced current in rat dissociated cultured hippocampal neuronsProtected against glutamate toxicity(Wang et al. 1999)Organophosphates-induced toxicity in ratsProtected the rats against seizure and status epilepticus(Coleman et al. 2008)SinomenineMorphine-treated SH-SY5Y cellsInhibited the morphine-induced activation of astrocytes(Ou et al. 2018)Mouse model of chronic inflammatory painAlleviated chronic pain(Li et al. 2017)PiperineIn a culture of primary hippocampal neuronsProtected against glutamate-induced decline in cell viability and apoptosis(Fu et al. 2010)IbogaineAddiction models in ratsReduced opioid and stimulant self-administration behavior(Glick and Maisonneuve 1998)TerpenoidsBilobalideNMDA-treated rat hippocampal slicesProtected against NMDA-induced breakdown of membrane phospholipids(Klein et al. 2003)NMDA-induced seizures in ratsInhibited choline release and reduced the incidence of convulsions in the NMDA-treated rats(Weichel et al. 1999)FucoxanthinExcitatory signaling mediated by ionotropic glutamate receptors (iGluRs), using the patch-clamp technique in juvenile miceAttenuated the spontaneous firing activity of Substantia Gelatinosa Neurons(Le et al. 2025)NMDA: N-methyl-D- aspartate Table 2The main experimental models employed in testing the NMDA-inhibiting activities of some phytochemicalsPhytochemical ClassPhytochemical compoundModelImpact of inhibiting NMDAReferenceGlycosidesVitexinCultured cortical neuronsReducing neuronal apoptosis(Yang et al. 2014)Ginsenoside Rb1Secondary brain damage due to strokes in ratsReducing neuronal apoptosis and increasing the regional cerebral blood flow(Wang et al. 2017)Ginsenoside Rg1Repeated alcohol exposure-induced psychomotor and cognitive deficits in miceImproved the cognitive behavior, and suppressed the extrasynaptic NMDARs-mediated excitotoxic signaling(Huang et al. 2020a)Hydroxysafflor yellow ANMDAR-mediated neurotoxicity in rat primary neuronsPrevented excitotoxic neuronal death(Yang et al. 2010)Neuronal injury induced by oxygen and glucose deprivation in mice hippocampal slicesPrevented excitotoxic neuronal death(Wang et al. 2016)PolyphenolicsQuercetinBulbectomized miceAlleviated the signs of depression(Holzmann et al. 2015)ResveratrolNMDA-induced seizure in different modelsIncreased the NMDA-induced seizure thresholds and reduced neuronal death(Wang et al. 2019)HonokiolNMDA-induced seizures in miceIncreased the NMDA-induced seizure thresholds(Lin et al. 2005)MagnololNMDA-induced seizures in miceIncreased the NMDA-induced seizure thresholds(Lin et al. 2005)Compound MQANMDA-treated SH-SY5Y cellsInhibit NMDA-induced calcium influx(Tian et al. 2015)AlkaloidsCytisineCultured cortical neural injury induced by NMDAPrevented the decline in cell viability and prevented neuronal apoptosis(Li et al. 2013)Cerebral ischemic–reperfusion injury in miceReduced the brain infarction size and inhibited neuronal apoptosis(Zhao et al. 2018)Huperzine ANMDA-induced current in rat dissociated cultured hippocampal neuronsProtected against glutamate toxicity(Wang et al. 1999)Organophosphates-induced toxicity in ratsProtected the rats against seizure and status epilepticus(Coleman et al. 2008)SinomenineMorphine-treated SH-SY5Y cellsInhibited the morphine-induced activation of astrocytes(Ou et al. 2018)Mouse model of chronic inflammatory painAlleviated chronic pain(Li et al. 2017)PiperineIn a culture of primary hippocampal neuronsProtected against glutamate-induced decline in cell viability and apoptosis(Fu et al. 2010)IbogaineAddiction models in ratsReduced opioid and stimulant self-administration behavior(Glick and Maisonneuve 1998)TerpenoidsBilobalideNMDA-treated rat hippocampal slicesProtected against NMDA-induced breakdown of membrane phospholipids(Klein et al. 2003)NMDA-induced seizures in ratsInhibited choline release and reduced the incidence of convulsions in the NMDA-treated rats(Weichel et al. 1999)FucoxanthinExcitatory signaling mediated by ionotropic glutamate receptors (iGluRs), using the patch-clamp technique in juvenile miceAttenuated the spontaneous firing activity of Substantia Gelatinosa Neurons(Le et al. 2025)NMDA: N-methyl-D- aspartate The main experimental models employed in testing the NMDA-inhibiting activities of some phytochemicals NMDA: N-methyl-D- aspartate Glycosides and glycoside derivatives with NMDAR-inhibiting effects Due to the glucosides' antioxidant and anti-inflammatory properties, the regular consumption of a glycoside-rich diet was related to reduced incidence of cognitive impairment and neurodegenerative diseases, including AD (Zhou et al. 2026). Vitexin Vitexin or Apigenin‐8‐C‐β‐D‐glucopyranoside is an apigenin flavone glycoside that is abundant in many plants, including buckwheat (Zielinska et al. 2007), hawthorn (Kirakosyan et al. 2003), Echinodorus (Tanus-Rangel et al. 2010), bamboo (Wang et al. 2012), mung bean (Cao et al. 2011), and Passiflora (Gadioli et al. 2018). Studies showed that vitexin has induced potent hypotensive, anti-inflammatory, and neuroprotective activities (Mustapha and Mat Taib 2023; Yan et al. 2025). As a flavonoid, vitexin can effectively cross the blood–brain barrier (BBB) and can act on a multiplicity of molecular targets, either by reducing the oxidative stress through its antioxidant effects or by even inducing the expression of the endogenous antioxidant enzymes (Lima et al. 2018). Interestingly, in a study conducted to investigate the effect of NMDA and glycine toxicity on cultured cortical neurons, vitexin showed a significant inhibition of NMDA-induced neurotoxicity in primary cortical neurons, chiefly due to the downregulation of the GluN2B subunit and subsequent reduction in calcium influx and intracellular calcium overload, reducing neuronal apoptosis (Yang et al. 2014). The primary limitation of the study investigating the effect of vitexin on NMDA transmission is its exclusive reliance on an in vitro model using primary cultures of mouse cerebral cortical neurons. This approach lacks in vivo validation and fails to account for the blood–brain barrier or complex systemic pharmacokinetic processes. Ginsenosides Ginsenosides are steroid glycosides that constitute the main active compounds in ginseng (Chopra et al. 2023), as they can be used as marker compounds for ginseng quality control and standardization in official monographs (Qi et al. 2011). Around 150 ginsenosides have been isolated and recognized from ginseng's fruits, roots, leaves, flower buds, and processed products (Im and Nah 2013), which account for the biological activities of ginseng represented in metabolism and immunity effects, antioxidant, anticancer, and cardiovascular system benefits (Liu et al. 2020; Sun et al. 2016). Ginsenosides can be categorized into three classes based on their chemical structure: protopanaxadiols, protopanaxatriols, and oleanane (ginsenosides Ro), with protopanaxadiols and protopanaxatriols having stronger activity. Protopanaxadiols contain sugar moieties on the C-3 position and include Rb1, Rb2, Rc, Rd, Rg3, and Rh2. Protopanaxatriols have sugar moieties on the C-6 position and include ginsenosides Re, Rf, Rg1, Rg2, and Rh1 (Zhou et al. 2024). Ginsenosides were found to penetrate the BBB; however; there penetration is poor (Fernández-Moriano et al. 2017). It was reported that ginsenoside Rb1 boosts regional cerebral blood flow and maintains neuronal ultrastructure. It mitigated glutamate excitability, inhibited NMDAR expression, and consequently reduced intracellular calcium overload. These effects resulted in a decrease in the release of cytochrome C, reducing neuronal apoptosis, suggesting that Rb1 could be a potential neuroprotective agent to prevent secondary brain damage due to stroke (Ling et al. 2024; Wang et al. 2017). Moreover, ginsenoside Rd was proven to be able to inhibit NMDAR-activated currents and succeeding excitotoxicity by interfering with the phosphorylation of GluN2B of the NMDAR through the alleviation of death-associated protein kinase 1-mediated (DAPK1) activity, achieved by inhibiting calcineurin (Zhang et al. 2020). Also, ginsenoside Rg1 was demonstrated to regulate the activity of the GluN2B-containing NMDARs, regulating cell signaling and alleviating excitotoxicity, which presents a potential therapeutic alternative to prevent chronic alcohol intake-induced nerve damage (Huang et al. 2020a). The limitations of the studies performed on ginsenosides are represented in low oral bioavailability, poor solubility, and a limited understanding of how specific metabolites contribute to therapeutic effects. Quinochalcone Quinochalcone C-glycosides are flavonoid glycosides that are responsible for the yellow and red pigments of the safflower floret. One dominant fraction in the water extract of safflower petals is yellow pigments that are also called “safflower yellow”, including hydroxysafflor yellow A and anhydrosafflor yellow B (Adamska and Biernacka 2021). Hydroxysafflor yellow A is a major bioactive constituent isolated from Carthami flos, the flower of Carthamus tinctorius L. (Yue et al. 2013), that has been found to be useful in the clinical management of ischemic cerebrovascular disease. It has been evidenced that hydroxysafflor yellow A exhibits multiple biological benefits against neurological injuries, such as those induced by ischemia/reperfusion, due to its antioxidant, anti-inflammatory, and anti-apoptotic effects. These effects were reflected as relieving BBB damage (Xu et al. 2021; Zheng et al. 2025), reducing cerebral infarction, attenuating cerebral edema, promoting neurological recovery, and improving cognitive function (Yu et al. 2020, 2018). Hydroxysafflor yellow A crosses the blood–brain barrier (BBB), although its penetration is generally low due to its hydrophilic nature. However, its BBB permeability significantly improves during conditions of neurovascular injury, such as ischemic stroke, hemorrhage, or trauma, allowing for its neuroprotective effects (Li et al. 2024). An in vitro study was conducted to investigate the protective effect of hydroxysafflor yellow A on NMDAR-mediated neurotoxicity in rat primary neurons. Hydroxysafflor yellow A was found to prevent excitotoxic neuronal death and reverse the increased expression of the GluN2B subtype by NMDA stimuli (Yang et al. 2010). Another study was conducted to investigate the potential protective effects of hydroxysafflor yellow A against neuronal injury induced by oxygen and glucose deprivation (OGD) in mice hippocampal slices, and the results confirmed that hydroxysafflor yellow A inhibited the postsynaptic NMDAR activity and NMDAR-mediated neuronal depolarization and reduced the presynaptic glutamate release. Depending on the previous findings, it can be concluded that it inhibits the NMDAR-mediated increase in neuronal calcium concentration and NMDAR-dependent ischemic long-term potentiation produced by oxygen and glucose deprivation, thus protecting hippocampal neurons from excitotoxic damage (Wang et al. 2016; Yu et al. 2022). However, the studies performed on the effect of Hydroxysafflor yellow A on the NMDA transmission are limited by being performed on in vitro models. Polyphenolic phytochemicals with NMDAR-inhibiting effects Polyphenolic compounds are a diverse class of plant secondary metabolites that are structurally characterized by having at least one six-carbon aromatic ring directly attached to at least two phenolic hydroxyl groups. Polyphenolic phytochemicals can be further classified into five subgroups, including cinnamic acid, chalcones, flavonoids, procyanidins, and anthocyanins (Bravo 1998; Prabhu et al. 2021). In the plant, they play important roles, including giving the plant parts colors, fighting pathogens, protecting against UV-induced damage, chelating toxic metals, and scavenging free radicals (Ji et al. 2024; Stevenson and Hurst 2007). Polyphenols are well-known for their neuroprotective activities that emerged from their effects as antioxidants, modulators of signaling cascades and apoptotic process, and inhibitors of the accumulation of abnormal protein aggregates (Mattson and Cheng 2006; Ramassamy 2006). Moreover, radio-tracer studies demonstrated the existence of binding sites for polyphenolics in rat brain (Han et al. 2006). Some polyphenolic compounds can cross the BBB, and others are converted to active metabolites by gut microbiota, which can then cross the BBB, inducing their beneficial effects in the CNS (Domínguez-López et al. 2025). Flavonoids: Quercetin One of the most valuable groups of polyphenols is the flavonoids, which are broadly available in the human diet (Chang et al. 1993; Lemanowicz et al. 2025). Their antioxidant profile makes them potential candidates for protecting against neurodegenerative diseases. Their overall bioavailability and, principally, their existence in the brain tissue in vivo appear to participate in the demonstration of the neuroprotective ability of flavonoids (Azuma et al. 2002; Bellavite 2023; Oliveira et al. 2002). Quercetin is a major flavonoid of great interest for researchers because it and its glycoside derivatives are widely abundant and constitute a very high percentage of the flavonoids taken in the daily diet. Its strong antioxidant effect, due to scavenging ROS involved in oxidation reactions, contributes to its effect on preventing low-density lipoproteins oxidation. Therefore, it is considered a good candidate for managing several disorders like diabetes mellitus, neurodegenerative disorders, atherosclerosis, and cancer (Ishige et al. 2001; Vollmannová et al. 2024). Quercetin is known to tackle neurotoxicity and neurodegenerative diseases by raising cellular defensive mechanisms to face mitochondrial dysfunction, oxidative stress, neuroinflammation, and apoptosis (Grewal et al. 2021). The neuroprotective effects of quercetin were found to be mediated by its inhibitory effect on NMDAR. In a study performed to investigate the antidepressant effect of quercetin in olfactory bulbectomy mice, the inhibition of NMDAR was found to be a main contributor to its antidepressant effects (Holzmann et al. 2015). It was also evidenced that quercetin alleviates the signs of depression after exposing rats to chronic unpredictable mild stress through inhibiting NMDAR1 and α2δ−1 expression levels and interfering with α2δ−1 and NMDAR1 binding. α2δ−1 is a subunit of the voltage-activated Ca2+ channel and is known to be the binding site for gabapentinoids (Ahmad et al. 2021; Fuller-Bicer et al. 2009; Gee et al. 1996; M. Wang et al. 2024a, b, c). It is highly expressed in the hypothalamus (Ma et al. 2018). The increased expression of α2δ−1 is associated with an increase in the NMDAR current. It can interact with NMDAR to form the complex α2δ−1–NMDAR that mediates neuropathic pain, drug tolerance, pain hypersensitivity induced by chemical drugs or nerve damage, and depressive behavior (Deng et al. 2019; Huang et al. 2020b). However, the therapeutic evaluation of quercetin is complicated by its rapid metabolism, while existing studies are further limited by their use of short-term administration. Stilbenes: Resveratrol Stilbenes are a class of polyphenolic compounds that have been explored as promising neuroprotective agents due to their potent effect on multiple complicated cellular and molecular reactions impacting neurodegeneration (Begh et al. 2024; Reinisalo et al. 2015). They are believed to induce their favorable effects by exhibiting antioxidant and anti-inflammatory effects. Moreover, they enhance neurotrophic factors, inhibit protein aggregation, and modulate autophagy. Stilbenes also boost neurotrophic factors crucial for neuron growth and function (Al-Khayri et al. 2023; Gocmez et al. 2018). Additionally, stilbenes successfully prevent protein misfolding and degradation; therefore, hindering the progression of neurodegenerative disorders (Sweeney et al. 2017). Resveratrol is a well-known polyphenolic stilbene abundant in many fruits, including grapes, cranberries, and peanuts. It is well-known for its beneficial biological activities, represented in being a potent antioxidant, antiaging, and anti-inflammatory (Bejenaru et al. 2024). Experimental and preclinical studies have proven that resveratrol effectively attenuates the symptoms accompanying multiple neurologic illnesses, including ischemia, stroke, seizures, AD, and PD (Lopez et al. 2015; Pervaiz and Holme 2009; Shetty 2011). The neuroprotective effects of resveratrol have been attributed to the inhibition of glutamate-induced neurotoxicity and the associated calcium influx into neurons through binding to NMDAR (Zhang et al. 2015). Resveratrol hinders NMDAR-mediated entering currents into hippocampal neurons, excitatory field potentials in the medial prefrontal cortex, and firing frequency in the spinal trigeminal nucleus caudalis (Gao et al. 2006; Takehana et al. 2017; Wang et al. 2019). Furthermore, resveratrol represses NMDA-induced seizure and neuronal death (Wang et al. 2019; Yang et al. 2017). On the other hand, it did not affect the baroreflex responses through the fetal hypothalamus–pituitary–adrenal axis in response to NMDA (Knutson and Wood 2010). This discrepant effect can be explained by contributions from different NMDAR subtypes. Resveratrol was found to be an effective inhibitor of NMDA-provoked cell death only in mature rat primary cortical neurons, but not in the immature neurons. Moreover, it attenuated NMDA-induced calcium influx in a concentration-dependent manner, in all NMDAR subtypes; however, it exhibited GluN2 subunit selectivity (Hsieh et al. 2021). It was found that NMDARs activation increases cellular lipid and calcium levels under the control of nitrated amyloid beta (Aβ) oligomers, which is implicated in AD, and hence induces more and more excitotoxicity, which is a feature of the disease (Zhang et al. 2018). Moreover, the internalization of synaptic NMDARs, from the synapse surface into cytoplasm by endocytosis, is implicated in the insufficiencies in long-term potentiation and synaptic loss in AD (Escamilla et al. 2024; Moretto and Passafaro 2018). Resveratrol showed maintenance of the stability of the membrane, reduction in the Aβ peptides-induced toxicities in the brain, inhibition of neuronal hyperexcitability, correction of synaptic transmission disorders induced by astrocyte changes, and improvement of synaptic plasticity, demonstrating protective effects against pathological alterations in key membrane NMDARs. Therefore, resveratrol noticeably induces neuroprotective effects against AD (Ai et al. 2015; Yan et al. 2020). Resveratrol was also found to inhibit the activation of protein kinase C gamma (PKCγ) and the phosphorylation of NMDAR GluN1, which normally controls receptor trafficking and surface expression, in the spinal trigeminal nucleus of rats with chronic constriction injury (CCI). These effects lead to weakening of NMDAR-mediated currents and consequently reduced NMDA-mediated excitotoxicity and the associated neuronal death (Virgili and Contestabile 2000; Yang et al. 2016). Although resveratrol showed promising neuroprotective results both in vivo and in vitro, human clinical trials have yielded mixed results, with poor oral bioavailability limiting its overall therapeutic efficacy (Puranik et al. 2025). Lignans: Magnolol and honokiol Lignans are plant-derived non-flavonoid polyphenols with estrogen-resembling structural features; therefore, known as phytoestrogens with estrogen receptor modulatory effects on the human body (Bolgova et al. 2025; Li et al. 2023). The major source of lignans is the flaxseed, whose digestion by gut microbiota yields more active and bioavailable metabolites known as enterolignans that exert potent estrogen modulatory, antioxidant, and anticarcinogenic activities (Parikh et al. 2019). Therefore, lignan-rich foods are considered potential nutraceuticals for protecting against human chronic diseases and cancers (Baldi et al. 2023). Honokiol and magnolol are isomers of hydroxylated biphenolic compounds that are considered the major bioactive constituents of the bark of Magnolia officinalis (Poivre and Duez 2017). Honokiol, a phenylpropanoid compound that belongs to the class of neolignanes, is a major constituent of M. officinalis bark that has been regarded as an herbal treatment for nervous disorders such as anxiety (Maruyama et al. 1998). Honokiol readily crosses the BBB and appears in the cerebrospinal fluid (Khodir et al. 2025). Multiple studies have presented evidence on the neuroprotective activity of honokiol in the CNS that can be attributed to its antioxidant and anti-inflammatory activities; besides the alleviation of glutamate-induced excitotoxicity, mainly due to the blockade of NMDA receptors (Talarek et al. 2017). Honokiol demonstrated a neuroprotective effect against focal cerebral ischemia–reperfusion injury by exerting antioxidant and anti-inflammatory activities (Le et al. 2024; Liou et al. 2003). Moreover, pretreatment with honokiol significantly reduced the lethality induced by NMDA administration and alleviated the behavioral signs of NMDA neurotoxicity, probably by restoring the levels of reduced glutathione and reducing lipid peroxidation in the brain tissue (Cui et al. 2007; Le et al. 2024). The study of honokiol in mice is limited by the use of an acute mouse model that does not account for chronic neurodegenerative disease progression. Furthermore, the study lacks detailed pharmacokinetic data regarding brain bioavailability and relies on a narrow examination of oxidative markers. Magnolol, the isomer of honokiol, is another major lignan abundant in the M officinalis bark (Yang et al. 2024). Magnolol is a small molecule that can easily cross the BBB (Lin et al. 2021b). Similar to honokiol, magnolol was demonstrated to exert neuroprotective activities that can be explained by its antioxidant, anti-inflammatory, and NMDA inhibitory effects. Magnolol protected the cortical neurons against hypoxia and mitigated stroke-induced neuronal damage (Chang et al. 2003; Lee et al. 1998; Wang et al. 2025). In vitro, in an experiment conducted on cultured rat cerebellar granule cells, it blocked the glutamate receptors and reduced both NMDA- and non-NMDA-activated calcium and sodium influx (Lin et al. 2005). In vivo, it induced anticonvulsant activity against NMDA-induced seizures (Yip et al. 2025). Quinic acid derivatives: Compound MQA 1,5-O-dicaffeoyl-3-O-(4-malic acid methyl ester)-quinic acid, or MQA, is a naturally extracted caffeoylquinic acid derivative that was recently isolated from the roots of Arctium lappa L (Tian et al. 2015). Being a caffeoylquinic acid derivative suggests that it acquires a wide range of biological activities, such as antioxidant, antibacterial, and antiproliferative effects (Chen et al. 2019; Fiamegos et al. 2011; Ooi et al. 2011; Zhao et al. 2014). SH-SY5Y cell line is a useful, in vitro tool for studying the NMDAR-induced currents because of its high expression on the cell membrane (Ndountse and Chan 2008; Petroni et al. 2013; Zhou et al. 2014). Pretreatment with MQA was demonstrated to inhibit NMDA-induced calcium influx and neuronal death after SH-SY5Y cells were treated with NMDA. This inhibitory mechanism involves the correction of extracellular signal-regulated kinase/cAMP response element-binding protein (ERK-CREB), protein kinase B (AKT), glycogen synthase kinase-3 beta (GSK-3β), p38 mitogen-activated protein kinase (p38), and c-Jun N-terminal kinases 1 and 2 (JNK1/2) pathway (Tian et al. 2015). Although this study indicated that MQA protected SH-SY5Y cells against NMDA-induced toxicity in vitro, it is limited by the lack of in vivo validation, physiological complexity, and determined pharmacokinetic data in living organisms. Additionally, the study does not outline the precise molecular binding sites for the compound and relies on an acute, rather than chronic, neurotoxicity model. Alkaloids with NMDAR-inhibiting Effects Alkaloids, nitrogen-containing phytochemicals, exhibit multiple biological properties (Bhambhani et al. 2021). Current studies have evidenced that they are able to modulate signaling pathways linked to numerous diseases. Due to their antioxidant effects, alkaloids were found to be beneficial in treating neurodegenerative diseases by concurrently affecting multiple pathological events and reducing chronic neuroinflammatory responses. Alkaloids were found to be able to interact with multiple cellular and molecular targets, such as transcription factors, receptors, and enzymes involved in the processes of neuronal survival and homeostasis (Utpal et al. 2025). Cytisine Cytisine is an alkaloid that is mainly isolated from Cytisus seeds and the other members of the family Fabaceae (X. Wang et al. 2024a, b, c). Because it acts as a nicotinic receptor partial agonist, it has been recognized as a therapy for treating nicotine addiction (Etter 2006; Ofori et al. 2023; Tutka et al. 2019). Although less than nicotine, cytisine can cross the BBB adequately (Simeonova et al. 2010). Moreover, studies demonstrated that cytisine also exhibits antidepressant-like activity (Han et al. 2016; Mineur et al. 2007) and attenuates CNS inflammation by inhibiting T-lymphocyte activities (Nizri et al. 2007). Furthermore, it was shown to protect the striatal dopamine tissue after exposure to 6-hydroxydopamine; therefore, exhibiting antiparkinsonian effects (Abin-Carriquiry et al. 2008; Zarate et al. 2021). Cytisine induced protective effects against the decline in cell viability after exposure to NMDA in a concentration-dependent pattern. It also showed that cytisine substantially prevented neuronal apoptosis produced by NMDA and reduced the intracellular calcium overload. It markedly inverted the up-regulation of GluN2B-containing NMDARs after exposure to NMDA, with no effect on that of GluN2A-containing NMDA receptors. This study demonstrated cytisine's neuroprotective effects in cultured neurons; however, it relied on an in vitro design lacking the in vivo validation and failed to address potential sex-specific differences in receptor response. Moreover, the study focused on a single mechanism of action and did not discuss the systemic side effects (Li et al. 2013). Another study conducted to emphasize the protective role of cytisine against cerebral ischemic–reperfusion injury in mice revealed that it reduced the brain infarction size and inhibited neuronal apoptosis. Furthermore, it alleviated the histopathological alterations by provoking the phosphorylation of extracellular signal-regulated kinase (ERK), CREB, and their mRNAs. On the contrary, cytisine reduced the expression of GluN2B (Zhao et al. 2018). Huperzine A It is known as a reversible, selective inhibitor of acetylcholinesterase (AChE), and shows high value in enhancing cognitive functions in various animal models (Cheng et al. 1996; Zhu et al. 2025). Huperzine A has a favorable safety profile and kinetics as it is a lipophilic alkaloid that readily crosses the BBB via passive diffusion; hence, it is considered a good candidate for treating neurodegenerative diseases (Friedli and Inestrosa 2021; Zhu et al. 2025). Huperzine A inhibited the NMDA-induced current in rat dissociated cultured hippocampal neurons, protecting against glutamate toxicity (Wang et al. 1999). Huperzine A was found to inhibit glutamate toxicity and alleviate oxidative stress in mouse-derived hippocampal cells (Mao et al. 2016). These in vitro studies are limited by the lack of in vivo validation of huperzine A effects. Organophosphates are known to induce seizures through a mechanism that depends on the excessive release of excitatory neurotransmitters because of excessive acetylcholine accumulation. Interestingly, huperzine A effectively protected the rats against seizure and status epilepticus induced by organophosphates through blocking the glutamate excitotoxicity. This study is limited by its reliance on an acute rat model with immediate, post-exposure administration, which makes it difficult to translate to the human clinical picture (Coleman et al. 2008). Sinomenine Sinomenine is a natural compound obtained from the medicinal plant Sinomenium acutum, and studies indicate that it is distributed to the brain after oral administration (Gao et al. 2019). Through many experimental studies, sinomenine exhibited multiple therapeutic effects against many diseases, including rheumatoid arthritis (Xu et al. 2008), pain (Jiang et al. 2020), atherosclerosis (Zhang et al. 2021), and cancer (Yan et al. 2023). These effects can be attributed to its broad-spectrum pharmacological activities, including anti-inflammatory, antioxidant, and anti-neoplastic effects (Gao et al. 2019; Jiang et al. 2020; Xu et al. 2008; Zhang et al. 2021). Besides its effects on peripheral tissues, and because it readily crosses the BBB, sinomenine exhibits therapeutic potential on CNS diseases (Gao et al. 2019; Liu et al. 2005; Long et al. 2010; Ou et al. 2018). Besides its antioxidant and anti-inflammatory effects, sinomenine was also found to suppress NMDAR-mediated calcium influx and induce γ-aminobutyric acid type A receptor-mediated chloride influx; therefore, it induces improvement in morphine dependence and sleep disturbance (Lin et al. 2021a; Ou et al. 2018; Yoo et al. 2017). It was also found to reduce the expression of NMDAR in morphine-treated SH-SY5Y cells (Ou et al. 2018). In a mouse model of chronic inflammatory pain, the systemic administration of sinomenine attenuated the upregulation of GluN2B-containing NMDAR and Ca2+/calmodulin-dependent protein kinase II. Furthermore, sinomenine administration attenuated the total levels of glutamate receptor 1, and its phosphorylation at Ser831 (p-GluA1-Ser831) in the anterior cingulate cortex region, which is highly associated with chronic pain processing (Li et al. 2017). Sinomenine has shown effectiveness in alleviating chronic pain through mechanisms related to the deactivation of NMDARs and suppressing central sensitization by halting ATP and ROS production in the CNS and reducing the gene expression of nociception protein via inhibition of protein kinase B activity (Jiang et al. 2020). Collectively, it is clear that the effect of sinomenine on NMDA transmission has been extensively studied both in vivo and in vitro. Moreover, it can readily cross the BBB; therefore, it may represent a good candidate for evaluating its clinical effectiveness and safety. Piperine In traditional medicine, black pepper has been recognized as a potent analgesic and anti-inflammatory agent that is useful in treating ear-nose-throat disorders (Takooree et al. 2019). Piperine, the major alkaloid of black pepper, has demonstrated cytoprotective, antioxidant (Jaisin et al. 2020; Rauscher et al. 2000; Selvendiran et al. 2003), immunomodulatory, and antitumor activities (Sunila and Kuttan 2004; Zadorozhna et al. 2019). On the CNS, piperine showed antidepressant and cognitive-enhancing effects with prolonged intake, owing to its effects on serotonin, norepinephrine, and GABA (Wattanathorn et al. 2008). Moreover, it was found to have a high BBB permeation potential (Eigenmann et al. 2016). In a culture of primary hippocampal neurons, pretreatment with piperine exhibited protective effects on the glutamate-induced decline in cell viability and apoptosis of hippocampal neurons, suggesting that the neuroprotective effects of piperine are potentially related to the regulation of neuronal network harmonization, presynaptic glutamic acid release, and calcium overload. The studies performed on piperine are limited by their dependence on the in vitro design, which fails to account for BBB permeability, metabolism, or in vivo pharmacokinetics. Additionally, the study lacks the complex neural network interactions and behavioral assessments found in whole-organism models, failing to tackle potential in vivo neurotoxicity and, accordingly, translation into clinical study (Fu et al. 2010; Hsieh et al. 2019). Ibogaine Ibogaine is an indole alkaloid extracted from the root bark of the African shrub Tabernanthe iboga, which demonstrates central stimulant and tremorigenic activities (Cherian et al. 2024; Zetler et al. 1972). Ibogaine readily crosses the BBB because it is a highly lipophilic compound. It readily penetrates the CNS to interact with various neurological and neurotransmitter receptors (Kontrimaviciūte et al. 2006). It has drawn attention because of its potential therapeutic effects against opiate, stimulant, and alcohol abuse (Köck et al. 2022). Ibogaine was found to be an effective competitor of the potent NMDAR antagonist, [3H]MK-801, in rat forebrain (Popik et al. 1994). It has been evidenced that ibogaine's NMDAR blocking activity in the rat's brain contributed to its effects on opioid and stimulant self-administration behavior, where pretreatment with ibogaine decreased the extracellular levels of dopamine in the nucleus accumbens of the rat brain (Glick and Maisonneuve 1998). Moreover, in whole-cell recordings from cultured rat hippocampal neurons, it induced a slow, concentration-dependent blockade of NMDA-induced currents, inhibiting glutamate-induced cell death. However, this study is limited to examining the neuroprotective effects of ibogaine only in vitro (Chen et al. 1996). In addition, at doses previously reported to interfere with drug-seeking behaviors, ibogaine substitutes as a discriminative stimulus in mice trained to discriminate against the prototypic voltage-dependent NMDA antagonist, dizocilpine, from saline. Although showing promising results, the study had a limited focus on physical withdrawal markers and failed to account for active metabolites like noribogaine (Popik et al. 1995). Terpenoids with NMDAR-inhibiting effects Terpenoids are a modified class of terpenes, the largest group of secondary metabolites that are derived from the association of a 5-carbon isoprene unit. Terpenoids are detected in all classes of living organisms, such as bacteria, fungi, and plants. They play a key role in all plant interactions with other organisms, including plant reproduction, defense, and signaling (Gershenzon and Dudareva 2007; Wang et al. 2023). The neuroprotective activities of terpenoids can be explained by their NMDA antagonistic activities. Bilobalide Bilobalide, a sesquiterpene lactone, is one of the main active compounds in the extract of Ginkgo biloba green leaves (Jensen et al. 2002). Bilobalide was found to cross the BBB readily and reach extracellular concentrations in the brain that allow efficient interaction with target molecules and neurotransmitter receptors (Lang et al. 2010). In vitro studies have demonstrated the efficacy of this compound in alleviating the after-effects of hypoxia in hippocampal slices (Klein et al. 1997), protecting against excitotoxicity-induced neuronal death (Chandrasekaran et al. 2003), and attenuating apoptotic cell death in neuronal cultures (Ahlemeyer et al. 1999). Bilobalide also protected against excitotoxic hippocampal membrane breakdown through inhibiting the NMDA-induced chloride flux through glycine/GABA-operated channels, thus avoiding NMDA-induced breakdown of membrane phospholipids (Klein et al. 2003). Moreover, bilobalide showed potent inhibitory effects on the NMDA-induced activation of phospholipase A2 and the associated phospholipid breakdown in the brain. Klein et al. 2003 study was limited by its in vitro rodent hippocampal slice methodology, which lacks the systemic pharmacokinetic and blood–brain barrier considerations of a living organism. Furthermore, the findings present a mechanistic contradiction regarding bilobalide's action on GABAergic receptors. In vivo, bilobalide significantly inhibited choline release and reduced the incidence of convulsions in the NMDA-treated rats (Weichel et al. 1999). Fucoxanthin Fucoxanthin is a xanthophyll-type carotenoid (tetraterpenoid natural pigment) that is commonly found in edible brown seaweeds. It is known as a potential medicinal agent with a great safety profile to humans (Oliyaei et al. 2023). Recent studies have suggested that fucoxanthin induces multiple physiological and beneficial biological activities, such as conferring anticancer, weight-loss, and antihypertensive effects (Kim et al. 2013; Seca and Pinto 2018). Owing to its potent antioxidant activity, it is considered a promising therapeutic agent for oxidative stress-related diseases. Its efficacy has been demonstrated in various in vitro models, such as UV-treated fibroblast cells (Tavares et al. 2020). Fucoxanthin can cross the BBB and accumulate in the brain tissue. However, its natural permeability is relatively low, and a significant portion is metabolized into its active derivative, fucoxanthinol, which also readily crosses the BBB (Pruccoli et al. 2024). In the substantia gelatinosa neurons of the trigeminal subnucleus caudalis of juvenile mice, fucoxanthin induced a dose-dependent inhibition of NMDA currents, protecting the mice's neurons from glutamate-induced excitotoxicity. However, this study is limited by its ex vivo methodology on juvenile mice, which fails to account for complex systemic environments or adult neurobiology. Moreover, the findings do not tackle the bioavailability of fucoxanthin (Le et al. 2025). Conclusion Phytochemicals, including glycosides, polyphenols, alkaloids, and terpenoids, represent a relatively safe and highly effective therapeutic alternative for CNS-related disorders through their inhibitory effects on NMDA receptor signaling, either by receptor blockade or by interfering with its expression in neurons. Multiple in vivo and in vitro models emphasized the neuroprotective effects of phytochemicals in alleviating glutamate excitotoxicity, reducing neuronal apoptosis, increasing cellular viability, and improving behavioral parameters via modulating NMDA transmission. Phytochemical compounds that showed enough evidence in the in vitro and in vivo studies, and demonstrated significant penetration through the BBB, including quercetin, resveratrol, honokiol, magnolol, cytisine, huperzine A, sinomenine, ibogaine, and bilobalide, provide evidence for probable future clinical application. On the other hand, compounds that were tested only in vitro, including vitexin, hydroxysafflor yellow A, MQA, and piperine, are still potential candidates, and further investigations in in vivo models may reveal neuroprotective activities. Concerning the phytochemicals, including ginsenoside Rb1, hydroxysafflor yellow A, and fucoxanthin, that exhibited poor bioavailability and weak distribution into the CNS, advanced drug delivery systems can enhance their penetration and allow taking advantage of their protective activities.